Medicus Pharma (NASDAQ:MDCX) Earns Buy Rating from D. Boral Capital
D. Boral Capital reiterated their buy rating on shares of Medicus Pharma (NASDAQ:MDCX – Free Report) in a research report released on Thursday morning,Benzinga reports. D. Boral Capital currently has a $27.00 price objective on the stock. MDCX has been the subject of several other reports. Maxim Group raised their price objective on Medicus Pharma […]
D. Boral Capital reiterated their buy rating on shares of Medicus Pharma (NASDAQ:MDCX – Free Report) in a research report released on Thursday morning,Benzinga reports. D. Boral Capital currently has a $27.00 price objective on the stock. MDCX has been the subject of several other reports. Maxim Group raised their price objective on Medicus Pharma […]
